Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
2022 StandoutNobel
Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census
2004
Endovascular Stent–Graft Placement for the Treatment of Acute Aortic Dissection
1999 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing
2010 Standout
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
2003
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Oral Anticoagulant Therapy
2012 Standout
Obesity in menopause – our negligence or an unfortunate inevitability?
2017 Standout
A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China
2010
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Albumin–drug interaction and its clinical implication
2013 Standout
Effectiveness of Exercise on Visceral Adipose Tissue in Older South Asian Women
2016
Aortic Dissection
1995
Empathy: Its ultimate and proximate bases
2002 Standout
Clinical, Diagnostic, and Management Perspectives of Aortic Dissection
2002
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates
2000
Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China
2008
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Cerebellar induced aphasia: case report of cerebellar induced prefrontal aphasic language phenomena supported by SPECT findings
1996
Will tomorrow's medicines work for everyone?
2004
Computational design of an enantioselective molecular imprinted polymer for the solid phase extraction of S-warfarin from plasma
2014
Genetic and clinical factors relating to warfarin dosing
2009
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis
2013
Event-related brain response abnormalities in autism: evidence for impaired cerebello-frontal spatial attention networks
2001
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
2005 StandoutNobel
Voriconazole potentiates warfarin‐induced prothrombin time prolongation
2003
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
Metabolic Syndrome and Menopause
2015
Hemostatic Management of Tooth Extractions in Patients on Oral Antithrombotic Therapy
2008
Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9 * 3 allele
2000
Pharmacogenetics of Warfarin Elimination and its Clinical Implications
2001
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Clinical and echocardiographic findings in patients with suspected acute aortic dissection
1998
Comparative Pharmacokinetics of Vitamin K Antagonists
2005
Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine
2009
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Novel CYP2C9 Promoter Variants and Assessment of Their Impact on Gene Expression
2008
Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography–mass spectrometry after solid-phase extraction
2004
Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
2008
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences
2004
haplotype structure in European American warfarin patients and association with clinical outcomes
2005
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese
2006
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Genetic Determinants of Response to Warfarin during Initial Anticoagulation
2008
Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation
2005
An electrochemical sensor based on multiwall carbon nanotubes and molecular imprinting strategy for warfarin recognition and determination
2014
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans
2008
Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions
2005
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
2009
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
2017
Cytochrome P450-Mediated Drug Interactions
2000
Effects of Anticoagulation Intensity on Hemostatic Markers in Patients With Non-Valvular Atrial Fibrillation
2003
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity
2003
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance
2004
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Rapid noninvasive diagnosis and surgical repair of acute ascending aortic dissection
1994
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
2004
Risks and Benefits of Combined Use of Bucolome and Warfarin in Anticoagulation Therapy
2010
Genes and mutations causing retinitis pigmentosa
2013 Standout
CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
2005
Molecular imprinting: perspectives and applications
2016 Standout
Works of Sosuke Kimura being referenced
Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection
1997
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes
1998
Mycotic Aneurysm of the Right Coronary Artery
2006
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*
1998
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
2006
Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients
2003
5′-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients
2004
Metabolic syndrome among pre- and post-menopausal rural women in Bangladesh: result from a population-based study
2013
[Crossed "cerebral" diaschisis? Seven cases with unilateral cerebellar vascular lesion which showed decreased perfusion in the contralateral cerebral cortex].
1989
Early diagnosis and surgical intervention of acute aortic dissection by transesophageal color flow mapping.
1990
Emergency surgical intervention of acute aortic dissection with the rapid diagnosis by transesophageal echocardiography.
1991
Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
1999